is there a patent on semaglutide As the for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic Semaglutide patent expiry in India

In 2023, branded obesity drug sales reached $6 billion, and this figure is expected to grow exponentially as demand continues to rise and these medications are used to treat a broader range of diseases

In SURMOUNT-2, the mean WL was up to 15.7% with tirzepatide 15 mg compared to 3.3% WL with placebo at 72 weeks for people with obesity and T2D [47]

To assess the potential impact of individual studies on the meta-analysis results, a sensitivity analysis was conducted by sequentially removing one study at a time and recalculating the effect size and pooled estimate

In 1969, the company opened a new plant in Clinton, Indiana